About 1 results

GSK will provide a UC Berkeley researcher with a set of small molecules that were previously demonstrated to have promising activity against M. tuberculosis-infected macrophages in vitro. The UC Berkeley researcher will use his novel assays to assess whether the molecules’ anti-tubercular activities are due to activation of the host macrophages’ autophragy pathway.